Literature DB >> 15977910

Clinical practice guidelines in nephrology: evaluation, classification, and stratification of chronic kidney disease.

George R Bailie1, Katrin Uhlig, Andrew S Levey.   

Abstract

The National Kidney Foundation developed and oversees the Kidney Disease Outcomes Quality Initiative, a process that develops clinical practice guidelines in nephrology. Recent guidelines address the evaluation, classification, and stratification of chronic kidney disease (CKD). These guidelines provide, for the first time, a standard definition of CKD, classification of its stages, and suggestions for appropriate laboratory measurements for the assessment of kidney function. Also discussed are the association of level of kidney function with systemic complications that develop during CKD, and the risk of loss of kidney function and development of cardiovascular disease in CKD.

Entities:  

Mesh:

Year:  2005        PMID: 15977910     DOI: 10.1592/phco.25.4.491.61034

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  16 in total

1.  Changes in Conjunctival Hemodynamics Predict Albuminuria in Sickle Cell Nephropathy.

Authors:  Ali Kord Valeshabad; Justin Wanek; Santosh L Saraf; Bruce I Gaynes; Victor R Gordeuk; Robert E Molokie; Mahnaz Shahidi
Journal:  Am J Nephrol       Date:  2015-08-05       Impact factor: 3.754

2.  Contrast-induced nephropathy following chronic total occlusion percutaneous coronary intervention in patients with chronic kidney disease.

Authors:  Yuan-Hui Liu; Yong Liu; Ning Tan; Ji-Yan Chen; Ying-Ling Zhou; Jian-Fang Luo; Dan-Qing Yu; Li-Wen Li; Hua-Long Li; Piao Ye; Peng Ran
Journal:  Eur Radiol       Date:  2015-05-17       Impact factor: 5.315

Review 3.  Relative risk of renal disease among people living with HIV: a systematic review and meta-analysis.

Authors:  Fakhrul M Islam; Jianyun Wu; James Jansson; David P Wilson
Journal:  BMC Public Health       Date:  2012-03-23       Impact factor: 3.295

4.  Triage of frail elderly with reduced exercise tolerance in primary care (TREE). A clustered randomized diagnostic study.

Authors:  Yvonne van Mourik; Karel G M Moons; Loes C M Bertens; Johannes B Reitsma; Arno W Hoes; Frans H Rutten
Journal:  BMC Public Health       Date:  2012-05-28       Impact factor: 3.295

5.  Aliskiren prevents the toxic effects of peritoneal dialysis fluids during chronic dialysis in rats.

Authors:  Juan Pérez-Martínez; Francisco C Pérez-Martínez; Blanca Carrión; Jesús Masiá; Agustín Ortega; Esther Simarro; Syong H Nam-Cha; Valentín Ceña
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

6.  Severe hypertriglyceridemia and hypercholesterolemia accelerating renal injury: a novel model of type 1 diabetic hamsters induced by short-term high-fat / high-cholesterol diet and low-dose streptozotocin.

Authors:  Liang He; Lili Hao; Xin Fu; Mingshu Huang; Rui Li
Journal:  BMC Nephrol       Date:  2015-04-11       Impact factor: 2.388

7.  Hypoxic hepatitis in cardiac intensive care unit: a study of cardiovascular risk factors, clinical course, and outcomes.

Authors:  Norberto C Chávez-Tapia; Brenda V Balderas-Garces; Patricia Meza-Meneses; Magali Herrera-Gomar; Sandra García-López; Octavio Gónzalez-Chon; Misael Uribe
Journal:  Ther Clin Risk Manag       Date:  2014-02-25       Impact factor: 2.423

Review 8.  Postoperative pain management in patients with chronic kidney disease.

Authors:  Qutaiba A Tawfic; Geoff Bellingham
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2015 Jan-Mar

9.  Renal markers for assessment of renal tubular and glomerular dysfunction.

Authors:  Dejan Spasovski
Journal:  J Nephropharmacol       Date:  2013-07-01

10.  How common are neurocognitive disorders in patients with chronic kidney disease and diabetes? Results from a cross-sectional study in a community cohort of patients in North Wales, UK.

Authors:  Peter Hobson; Aled Lewis; Hari Nair; Stephen Wong; Mick Kumwenda
Journal:  BMJ Open       Date:  2018-12-04       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.